Cargando…
Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes
Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745462/ https://www.ncbi.nlm.nih.gov/pubmed/35011962 http://dx.doi.org/10.3390/jcm11010218 |
_version_ | 1784630351020163072 |
---|---|
author | Pata, Francesco Bracchitta, Luigi Maria D’Ambrosio, Giancarlo Bracchitta, Salvatore |
author_facet | Pata, Francesco Bracchitta, Luigi Maria D’Ambrosio, Giancarlo Bracchitta, Salvatore |
author_sort | Pata, Francesco |
collection | PubMed |
description | Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and third-degree HD. Methods: A retrospective analysis of second- and third-degree HD cases from November 2017 to August 2021 was performed. Patients on anticoagulants or with other HD degrees were excluded. Follow-up was conducted at 1 month, 3 months, 6 months, 1 year and then every 12 months. Results: 97 patients with second- (20 pts; 20.6%) and third-degree (77 pts; 79.4%) HD with a mean age of 52 years (20–84; SD ± 15.5) were included. Fifty-six patients were men (57.7%) and forty-one women (42.3%). Median follow-up was 13 months (1–26 months). No intraoperative adverse events or drug-related side effects occurred. Minor complications occurred in four patients (4.1%) in the first 30 postoperative days and all resolved after conservative treatment at the 3-month follow-up visit. No mortality or readmissions were observed. Conclusions: Sclerobanding is a safe technique with a low rate of minor postoperative complications. Further studies on larger samples are necessary to establish the effectiveness and long-term outcomes of the technique. |
format | Online Article Text |
id | pubmed-8745462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87454622022-01-11 Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes Pata, Francesco Bracchitta, Luigi Maria D’Ambrosio, Giancarlo Bracchitta, Salvatore J Clin Med Article Background: Sclerobanding is a novel technique combining rubber band ligation with 3% polidocanol foam sclerotherapy for the treatment of hemorrhoidal disease (HD). The aim of this study is to evaluate the feasibility, safety and short-term outcomes of sclerobanding in the treatment of second- and third-degree HD. Methods: A retrospective analysis of second- and third-degree HD cases from November 2017 to August 2021 was performed. Patients on anticoagulants or with other HD degrees were excluded. Follow-up was conducted at 1 month, 3 months, 6 months, 1 year and then every 12 months. Results: 97 patients with second- (20 pts; 20.6%) and third-degree (77 pts; 79.4%) HD with a mean age of 52 years (20–84; SD ± 15.5) were included. Fifty-six patients were men (57.7%) and forty-one women (42.3%). Median follow-up was 13 months (1–26 months). No intraoperative adverse events or drug-related side effects occurred. Minor complications occurred in four patients (4.1%) in the first 30 postoperative days and all resolved after conservative treatment at the 3-month follow-up visit. No mortality or readmissions were observed. Conclusions: Sclerobanding is a safe technique with a low rate of minor postoperative complications. Further studies on larger samples are necessary to establish the effectiveness and long-term outcomes of the technique. MDPI 2021-12-31 /pmc/articles/PMC8745462/ /pubmed/35011962 http://dx.doi.org/10.3390/jcm11010218 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pata, Francesco Bracchitta, Luigi Maria D’Ambrosio, Giancarlo Bracchitta, Salvatore Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title | Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title_full | Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title_fullStr | Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title_full_unstemmed | Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title_short | Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes |
title_sort | sclerobanding (combined rubber band ligation with 3% polidocanol foam sclerotherapy) for the treatment of second- and third-degree hemorrhoidal disease: feasibility and short-term outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745462/ https://www.ncbi.nlm.nih.gov/pubmed/35011962 http://dx.doi.org/10.3390/jcm11010218 |
work_keys_str_mv | AT patafrancesco sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes AT bracchittaluigimaria sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes AT dambrosiogiancarlo sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes AT bracchittasalvatore sclerobandingcombinedrubberbandligationwith3polidocanolfoamsclerotherapyforthetreatmentofsecondandthirddegreehemorrhoidaldiseasefeasibilityandshorttermoutcomes |